Fund Overview of Nippon India Pharma Fund-growth
-
₹7,898.2 CrAUM
-
₹517.71NAV
-
1.78%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Nippon India Pharma Fund-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 6.48% | NA | 6.12% |
| 6 Months | 0.87% | NA | 12.92% |
| 1 Year | 4.93% | 4.93% | 6.04% |
| 2 Years | 20.63% | 9.83% | 24.93% |
| 3 Years | 83.77% | 22.49% | 25.71% |
| 5 Years | 90.39% | 13.74% | 19.91% |
| 7 Years | 234.73% | 18.84% | NA |
| 10 Years | 285.19% | 14.44% | 12.78% |
Asset Allocation
equities
99.45%debt instruments
0.01%other assets or cash equivalents
0.54%Nippon India Pharma Fund-growth is one Equity mutual fund offered by Nippon India Mutual Fund. Launched on 05 Jun 2004, the fund aims Long term capital growth. Investment in equity and equity related Securities of pharma & other associated companies. It manages assets worth ₹7,898.2 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.78%. Fund Manager Manager EducationAbout Nippon India Pharma Fund-growth
The portfolio allocation consists of 99.45% in equities, 0.01% in debt instruments, 0.54% in other assets or cash equivalents.Managed by Sailesh Raj Bhan, it has delivered a return of 4.93% in the last year, a total return since inception of 19.74%.
People planning wealth creation frequently compare the best sip plan in order to plan sustainable wealth.
Key Metrics of Nippon India Pharma Fund-growth
-
Standard Deviation15.71%
-
Sharpe Ratio0.96%
-
Alpha-0.98%
-
Beta0.91%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| UTI Healthcare Fund Direct-growth |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
| UTI Healthcare Fund Direct-idcw |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
More funds from Nippon India Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Nippon India Pharma Fund Direct-growth
|
₹7,898 | 4.54% | 6.71% | 1.32% | 5.88% | 23.59% |
|
Nippon India Pharma Fund-idcw
|
₹7,898 | 4.46% | 6.48% | 0.87% | 4.93% | 22.49% |
|
Nippon India Pharma Fund Direct-idcw
|
₹7,898 | 4.54% | 6.71% | 1.32% | 5.88% | 23.59% |
|
Nippon India Nifty Pharma Etf-growth
|
₹1,248 | 2.67% | 6.53% | 4.00% | 8.35% | 23.33% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹517.71 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹580.66 | 23.59% | 14.77% | 15.46% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹111.80 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹158.92 | 23.59% | 14.77% | 15.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹23.19 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹426.36 | 24.04% | 15.16% | 11.90% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹492.05 | 25.34% | 16.38% | 13.14% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.55% | ₹1,145.91 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.92% | ₹1,099.37 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.08% | ₹1,086.73 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.02% | ₹1,075.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.67% | ₹1,057.76 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.67% | ₹1,057.76 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.67% | ₹998.08 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.94% | ₹997.57 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.29% | ₹997.45 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.07% | ₹673.82 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.07% | ₹673.82 Cr |
| Lupin Ltd | Healthcare | 8.45% | ₹667.33 Cr |
| Lupin Ltd | Healthcare | 7.99% | ₹663.87 Cr |
| Lupin Ltd | Healthcare | 7.59% | ₹642.15 Cr |
| Lupin Ltd | Healthcare | 7.88% | ₹620.87 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.34% | ₹613.17 Cr |
| Lupin Ltd | Healthcare | 7.36% | ₹608.38 Cr |
| Lupin Ltd | Healthcare | 7.26% | ₹605.54 Cr |
| Lupin Ltd | Healthcare | 7.26% | ₹605.54 Cr |
| Lupin Ltd | Healthcare | 7.26% | ₹589.44 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.90% | ₹583.42 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.01% | ₹568.97 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.56% | ₹545.21 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.58% | ₹543.84 Cr |
| Cipla Ltd | Healthcare | 6.33% | ₹535.20 Cr |
| Cipla Ltd | Healthcare | 6.39% | ₹528.21 Cr |
| Cipla Ltd | Healthcare | 6.48% | ₹525.41 Cr |
| Cipla Ltd | Healthcare | 6.29% | ₹524.71 Cr |
| Cipla Ltd | Healthcare | 6.29% | ₹524.71 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.54% | ₹514.79 Cr |
| Cipla Ltd | Healthcare | 6.09% | ₹508.61 Cr |
| Lupin Ltd | Healthcare | 6.09% | ₹508.59 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.41% | ₹505.94 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.97% | ₹498.34 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.97% | ₹498.34 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.02% | ₹497.89 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.91% | ₹493.73 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.90% | ₹493.46 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.83% | ₹492.96 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.81% | ₹482.33 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.92% | ₹480.69 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.91% | ₹479.21 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.06% | ₹477.02 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.63% | ₹475.92 Cr |
| Cipla Ltd | Healthcare | 5.67% | ₹471.20 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.96% | ₹470.56 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.62% | ₹468.99 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.62% | ₹468.99 Cr |
| Cipla Ltd | Healthcare | 5.88% | ₹462.75 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.53% | ₹456.91 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.73% | ₹451.59 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.17% | ₹429.24 Cr |
| Cipla Ltd | Healthcare | 5.42% | ₹427.86 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.15% | ₹407.15 Cr |
| Medplus Health Services Ltd | Healthcare | 3.70% | ₹307.45 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.71% | ₹306.28 Cr |
| Medplus Health Services Ltd | Healthcare | 3.65% | ₹305.40 Cr |
| Medplus Health Services Ltd | Healthcare | 3.86% | ₹304.66 Cr |
| Medplus Health Services Ltd | Healthcare | 3.47% | ₹293.37 Cr |
| Medplus Health Services Ltd | Healthcare | 3.54% | ₹292.83 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.48% | ₹290.92 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.49% | ₹290.25 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.49% | ₹289.97 Cr |
| Medplus Health Services Ltd | Healthcare | 3.68% | ₹289.80 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.56% | ₹288.67 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.41% | ₹288.11 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.42% | ₹285.39 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.42% | ₹285.39 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.41% | ₹283.32 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.51% | ₹276.75 Cr |
| Medplus Health Services Ltd | Healthcare | 3.32% | ₹276.71 Cr |
| Medplus Health Services Ltd | Healthcare | 3.32% | ₹276.71 Cr |
| Medplus Health Services Ltd | Healthcare | 3.39% | ₹274.75 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.39% | ₹266.87 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.21% | ₹265.63 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.36% | ₹265.45 Cr |
| Gland Pharma Ltd | Healthcare | 3.24% | ₹263.00 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.24% | ₹255.79 Cr |
| Sai Life Sciences Ltd. | Healthcare | 3.07% | ₹255.13 Cr |
| Gland Pharma Ltd | Healthcare | 3.05% | ₹254.72 Cr |
| Gland Pharma Ltd | Healthcare | 3.05% | ₹254.72 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 3.04% | ₹254.33 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.06% | ₹254.25 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 3.15% | ₹248.66 Cr |
| Sai Life Sciences Ltd. | Healthcare | 3.15% | ₹248.42 Cr |
| Gland Pharma Ltd | Healthcare | 2.96% | ₹247.14 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.90% | ₹245.66 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.99% | ₹242.89 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.87% | ₹239.14 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.87% | ₹239.14 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.84% | ₹237.68 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.83% | ₹236.50 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.83% | ₹236.50 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.83% | ₹234.85 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.81% | ₹234.67 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.81% | ₹234.67 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.77% | ₹234.65 Cr |
| Gland Pharma Ltd | Healthcare | 2.75% | ₹232.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.81% | ₹232.16 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.85% | ₹230.84 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.87% | ₹226.90 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.67% | ₹226.03 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.73% | ₹225.90 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.81% | ₹222.09 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.71% | ₹219.97 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.63% | ₹219.38 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.78% | ₹219.32 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.77% | ₹218.52 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.57% | ₹217.72 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.59% | ₹216.40 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.59% | ₹216.40 Cr |
| Abbott India Ltd | Healthcare | 2.59% | ₹216.20 Cr |
| Abbott India Ltd | Healthcare | 2.61% | ₹215.33 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.71% | ₹213.44 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.52% | ₹210.77 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.47% | ₹208.86 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.51% | ₹208.66 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.64% | ₹208.49 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.50% | ₹207.79 Cr |
| Abbott India Ltd | Healthcare | 2.44% | ₹206.55 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.61% | ₹205.63 Cr |
| Abbott India Ltd | Healthcare | 2.60% | ₹204.50 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.41% | ₹201.55 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.44% | ₹201.42 Cr |
| Abbott India Ltd | Healthcare | 2.48% | ₹201.15 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.55% | ₹200.73 Cr |
| Abbott India Ltd | Healthcare | 2.39% | ₹199.13 Cr |
| Abbott India Ltd | Healthcare | 2.39% | ₹199.13 Cr |
| Abbott India Ltd | Healthcare | 2.37% | ₹196.82 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.35% | ₹196.27 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.37% | ₹195.76 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.32% | ₹193.91 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.32% | ₹193.91 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.45% | ₹192.68 Cr |
| Abbott India Ltd | Healthcare | 2.43% | ₹192.26 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.29% | ₹190.99 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.29% | ₹190.99 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.34% | ₹189.93 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.24% | ₹187.21 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.37% | ₹186.88 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.20% | ₹185.89 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.27% | ₹184.55 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.27% | ₹184.50 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.34% | ₹184.47 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.18% | ₹184.01 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.33% | ₹183.77 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.25% | ₹182.54 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.20% | ₹182.54 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.20% | ₹181.91 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.19% | ₹180.61 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.16% | ₹180.59 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.16% | ₹180.59 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.16% | ₹180.50 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.12% | ₹179.75 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.20% | ₹178.84 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.14% | ₹178.23 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.14% | ₹178.23 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.16% | ₹178.23 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.09% | ₹177.07 Cr |
| Biocon Ltd | Healthcare | 2.10% | ₹175.61 Cr |
| Biocon Ltd | Healthcare | 2.10% | ₹175.61 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.16% | ₹175.60 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.09% | ₹175.01 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.12% | ₹174.80 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.08% | ₹172.90 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.06% | ₹172.37 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.18% | ₹171.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.05% | ₹171.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.17% | ₹171.52 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.11% | ₹170.91 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.05% | ₹170.54 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.02% | ₹170.51 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.05% | ₹169.44 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.01% | ₹168.17 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.01% | ₹168.17 Cr |
| Biocon Ltd | Healthcare | 1.99% | ₹168.08 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.01% | ₹166.38 Cr |
| Pfizer Ltd | Healthcare | 1.99% | ₹165.78 Cr |
| Pfizer Ltd | Healthcare | 1.99% | ₹165.78 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.09% | ₹165.08 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.98% | ₹164.21 Cr |
| Pfizer Ltd | Healthcare | 1.96% | ₹164.09 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.93% | ₹163.35 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.07% | ₹163.34 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 1.95% | ₹162.37 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 1.95% | ₹162.37 Cr |
| Pfizer Ltd | Healthcare | 1.94% | ₹161.10 Cr |
| Biocon Ltd | Healthcare | 1.98% | ₹160.93 Cr |
| Pfizer Ltd | Healthcare | 1.98% | ₹160.27 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.02% | ₹159.84 Cr |
| Pfizer Ltd | Healthcare | 1.92% | ₹158.73 Cr |
| Pfizer Ltd | Healthcare | 1.87% | ₹158.33 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.94% | ₹153.53 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 1.82% | ₹150.85 Cr |
| Pfizer Ltd | Healthcare | 1.90% | ₹150.23 Cr |
| Gland Pharma Ltd | Healthcare | 1.88% | ₹147.83 Cr |
| Biocon Ltd | Healthcare | 1.76% | ₹147.23 Cr |
| Gland Pharma Ltd | Healthcare | 1.76% | ₹145.88 Cr |
| Pfizer Ltd | Healthcare | 1.84% | ₹145.24 Cr |
| Gland Pharma Ltd | Healthcare | 1.67% | ₹137.85 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹135.78 Cr |
| Repo | Unspecified | 1.64% | ₹135.68 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 1.67% | ₹132.26 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.50% | ₹125.19 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.50% | ₹125.19 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.48% | ₹123.88 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.48% | ₹123.88 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.51% | ₹119.08 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.51% | ₹118.77 Cr |
| Sanofi India Ltd | Healthcare | 1.42% | ₹118.45 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.43% | ₹116.25 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.39% | ₹116.23 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.35% | ₹114.05 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.35% | ₹112.93 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.35% | ₹112.93 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.33% | ₹110.79 Cr |
| Sanofi India Ltd | Healthcare | 1.32% | ₹110.08 Cr |
| Sanofi India Ltd | Healthcare | 1.32% | ₹110.08 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.35% | ₹109.80 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.35% | ₹109.31 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.39% | ₹109.25 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.30% | ₹108.73 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.31% | ₹108.63 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.29% | ₹107.99 Cr |
| Sanofi India Ltd | Healthcare | 1.32% | ₹107.08 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.32% | ₹107.06 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.27% | ₹105.77 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.27% | ₹105.07 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.24% | ₹104.69 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.25% | ₹104.06 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.23% | ₹103.65 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.32% | ₹103.62 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.24% | ₹103.47 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.24% | ₹103.47 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.23% | ₹102.31 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.23% | ₹102.31 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.23% | ₹101.84 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.20% | ₹101.46 Cr |
| Sanofi India Ltd | Healthcare | 1.19% | ₹101.04 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.24% | ₹100.86 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.20% | ₹100.62 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.18% | ₹99.56 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.18% | ₹97.58 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.17% | ₹96.57 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.15% | ₹95.92 Cr |
| Sanofi India Ltd | Healthcare | 1.14% | ₹94.12 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.19% | ₹94.00 Cr |
| Max Healthcare Institute Ltd | Healthcare | 1.13% | ₹93.15 Cr |
| Sanofi India Ltd | Healthcare | 1.17% | ₹92.52 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.16% | ₹91.83 Cr |
| Sanofi India Ltd | Healthcare | 1.10% | ₹91.31 Cr |
| Repo | Unspecified | 1.15% | ₹90.82 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.15% | ₹90.74 Cr |
| Syngene International Ltd | Healthcare | 1.09% | ₹89.87 Cr |
| Syngene International Ltd | Healthcare | 1.13% | ₹89.17 Cr |
| Suraksha Diagnostic Ltd. | Healthcare | 1.12% | ₹88.82 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.11% | ₹87.76 Cr |
| Biocon Ltd | Healthcare | 1.06% | ₹87.42 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.04% | ₹86.59 Cr |
| Biocon Ltd | Healthcare | 1.04% | ₹86.51 Cr |
| Syngene International Ltd | Healthcare | 1.00% | ₹83.24 Cr |
| Syngene International Ltd | Healthcare | 1.00% | ₹83.24 Cr |
| Syngene International Ltd | Healthcare | 0.98% | ₹83.01 Cr |
| Biocon Ltd | Healthcare | 1.03% | ₹81.41 Cr |
| Net Current Assets | Unspecified | 0.98% | ₹81.24 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.99% | ₹80.57 Cr |
| Syngene International Ltd | Healthcare | 0.96% | ₹80.15 Cr |
| Syngene International Ltd | Healthcare | 0.98% | ₹79.76 Cr |
| Syngene International Ltd | Healthcare | 0.96% | ₹79.52 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.90% | ₹75.16 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.90% | ₹75.16 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.89% | ₹74.23 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹73.97 Cr |
| Sanofi India Ltd | Healthcare | 0.94% | ₹73.91 Cr |
| Syngene International Ltd | Healthcare | 0.93% | ₹73.43 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹70.63 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.84% | ₹69.82 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.84% | ₹69.82 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.88% | ₹69.46 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.83% | ₹68.96 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.82% | ₹68.83 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.83% | ₹68.70 Cr |
| Repo | Unspecified | 0.86% | ₹68.02 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.79% | ₹67.18 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.82% | ₹66.89 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.85% | ₹66.60 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.78% | ₹65.53 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.76% | ₹64.54 Cr |
| Anthem Biosciences Ltd. | Healthcare | 0.81% | ₹63.44 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.74% | ₹62.02 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.74% | ₹62.02 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.74% | ₹60.19 Cr |
| Repo | Unspecified | 0.71% | ₹60.01 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.72% | ₹59.78 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.72% | ₹59.78 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.70% | ₹56.97 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.68% | ₹56.49 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.67% | ₹56.46 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.67% | ₹55.37 Cr |
| Indoco Remedies Ltd | Healthcare | 0.66% | ₹53.57 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.68% | ₹53.50 Cr |
| Biocon Ltd | Healthcare | 0.67% | ₹53.03 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.63% | ₹52.94 Cr |
| Indoco Remedies Ltd | Healthcare | 0.61% | ₹51.22 Cr |
| Indoco Remedies Ltd | Healthcare | 0.61% | ₹51.22 Cr |
| Indoco Remedies Ltd | Healthcare | 0.59% | ₹48.92 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.62% | ₹48.59 Cr |
| Indoco Remedies Ltd | Healthcare | 0.56% | ₹47.00 Cr |
| Indoco Remedies Ltd | Healthcare | 0.52% | ₹43.05 Cr |
| Indoco Remedies Ltd | Healthcare | 0.51% | ₹39.91 Cr |
| Repo | Unspecified | 0.47% | ₹39.20 Cr |
| Repo | Unspecified | 0.47% | ₹39.20 Cr |
| Orchid Pharma Ltd | Healthcare | 0.45% | ₹38.12 Cr |
| Repo | Unspecified | 0.46% | ₹37.52 Cr |
| Indoco Remedies Ltd | Healthcare | 0.45% | ₹37.12 Cr |
| Orchid Pharma Ltd | Healthcare | 0.43% | ₹36.17 Cr |
| Orchid Pharma Ltd | Healthcare | 0.43% | ₹35.79 Cr |
| Orchid Pharma Ltd | Healthcare | 0.43% | ₹35.79 Cr |
| Orchid Pharma Ltd | Healthcare | 0.42% | ₹34.73 Cr |
| Orchid Pharma Ltd | Healthcare | 0.43% | ₹34.59 Cr |
| Repo | Unspecified | 0.41% | ₹34.43 Cr |
| Indoco Remedies Ltd | Healthcare | 0.38% | ₹30.09 Cr |
| Repo | Unspecified | 0.34% | ₹28.00 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.23% | ₹19.05 Cr |
| Concord Biotech Ltd. | Healthcare | 0.22% | ₹18.79 Cr |
| Concord Biotech Ltd. | Healthcare | 0.23% | ₹18.41 Cr |
| Concord Biotech Ltd. | Healthcare | 0.19% | ₹16.13 Cr |
| Concord Biotech Ltd. | Healthcare | 0.19% | ₹16.13 Cr |
| Concord Biotech Ltd. | Healthcare | 0.19% | ₹15.84 Cr |
| Concord Biotech Ltd. | Healthcare | 0.18% | ₹15.04 Cr |
| Concord Biotech Ltd. | Healthcare | 0.16% | ₹13.64 Cr |
| Concord Biotech Ltd. | Healthcare | 0.17% | ₹13.13 Cr |
| Concord Biotech Ltd. | Healthcare | 0.14% | ₹11.38 Cr |
| Net Current Assets | Unspecified | 0.13% | ₹8.97 Cr |
| Net Current Assets | Unspecified | 0.10% | ₹5.00 Cr |
| Others Mrgn Money | Unspecified | 0.01% | ₹0.80 Cr |
| Others Mrgn Money | Unspecified | 0.01% | ₹0.43 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.26 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.26 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.23 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.21 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.07 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.06 Cr |
| Others Mrgn Money | Unspecified | 0.00% | ₹0.04 Cr |
| Net Payables | Unspecified | -0.02% | ₹-2.95 Cr |
| Net Payables | Unspecified | -0.11% | ₹-9.56 Cr |
| Net Payables | Unspecified | -0.14% | ₹-11.47 Cr |
| Net Payables | Unspecified | -0.14% | ₹-11.47 Cr |
| Net Payables | Unspecified | -0.18% | ₹-13.85 Cr |
| Net Payables | Unspecified | -0.32% | ₹-25.90 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹492.05 | 25.34% | 16.38% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹341.86 | 25.34% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹45.41 | 26.23% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹27.35 | 26.23% | 16.38% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹23.19 | 27.21% | 16.24% | - |
| UTI Healthcare Fund Direct-growth |
₹331.99 | 26.44% | 15.34% | - |
| UTI Healthcare Fund Direct-idcw |
₹256.60 | 26.44% | 15.34% | - |
Frequently Asked Questions
Nippon India Pharma Fund-growth
What is the current AUM of Nippon India Pharma Fund-growth?
As of Tue Mar 31, 2026, Nippon India Pharma Fund-growth manages assets worth ₹7,898.2 crore
How has Nippon India Pharma Fund-growth performed recently?
- 3 Months: 6.48%
- 6 Months: 0.87%
What is the long-term performance of Nippon India Pharma Fund-growth?
- 3 Years CAGR: 22.49%
- 5 Years CAGR: 13.74%
- Since Inception: 19.74%
What is the portfolio composition of Nippon India Pharma Fund-growth?
Equity: 99.45%, Debt: 0.01%, Others: 0.54%.
Who manages Nippon India Pharma Fund-growth?
Nippon India Pharma Fund-growth is managed by Sailesh Raj Bhan from Nippon India Mutual Fund.
What is the market-cap allocation of Nippon India Pharma Fund-growth?
Large Cap: 40.32%, Mid Cap: 28.63%, Small Cap: 31.05%.
Which are the top companies Nippon India Pharma Fund-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 13.55% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.92% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.08% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 13.02% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.67% of the fund's portfolio
Which are the major sectors Nippon India Pharma Fund-growth focuses on?
- Healthcare – 893.17% of the fund's portfolio
- Unspecified – 6.84% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





